XPAND Trial: Enhancing XP Photoprotection Activities - New Directions

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

March 30, 2018

Primary Completion Date

December 30, 2019

Study Completion Date

January 30, 2020

Conditions
Xeroderma Pigmentosum
Interventions
BEHAVIORAL

XPAND

The intervention is personalised to the psychosocial factors influencing poor photoprotection for each person. These factors could include beliefs that reduce motivation to protect as well as factors that prevent intentions being translated into action. The facilitator will use behaviour change techniques to target the factor most important for each person. Standardised content related to habit formation will be received. The intervention will be delivered via 7 1:1 sessions with a facilitator (psychologists or clinical nurse specialist). Sessions 1 (1.5 hours maximum) and 6 (45 minutes) will be delivered face to face in the home of the participant and the remaining sessions will be conducted via telephone calls or skype sessions.

Trial Locations (1)

SE1 7EH

Guy's St Thomas' NHS Foundation Trust, London

All Listed Sponsors
collaborator

King's College London

OTHER

collaborator

Newcastle University

OTHER

collaborator

University of Cambridge

OTHER

lead

Guy's and St Thomas' NHS Foundation Trust

OTHER

NCT03445052 - XPAND Trial: Enhancing XP Photoprotection Activities - New Directions | Biotech Hunter | Biotech Hunter